Evidence mapPaperPMID 39719617Full record

ArticleJournal of translational medicine2024

Predicting higher risk factors for COVID-19 short-term reinfection in patients with rheumatic diseases: a modeling study based on XGBoost algorithm.

Yao Liang, Siwei Xie, Xuqi Zheng, Xinyu Wu, Sijin Du, Yutong Jiang

Abstract read
In one paragraph

Article in Journal of translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yao Liang *Department of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Tianhe District, Guangzhou, China.
Siwei Xie *Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Xuqi ZhengDepartment of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Tianhe District, Guangzhou, China.
Xinyu WuDepartment of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Tianhe District, Guangzhou, China.
Sijin DuDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Yutong JiangDepartment of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Tianhe District, Guangzhou, China. Jiangyt7@mail.sysu.edu.cn.ORCID 0000-0001-6558-4201

Funding

2024 Basic and Applied Basic Research (Outstanding Doctoral Program) 2024A04J9909Guangdong Provincial Basic and Applied Basic Research Fund Project 2024A1515012734National Natural Science Foundation of China Youth Fund 82201998
6 · The paper itself

Abstract

backgroundCorona virus disease 2019 (COVID-19) reinfection, particularly short-term reinfection, poses challenges to the management of rheumatic diseases and may increase adverse clinical outcomes. This study aims to develop machine learning models to predict and identify the risk of short-term COVID-19 reinfection in patients with rheumatic diseases.

methodsWe developed four prediction models using explainable machine learning to assess the risk of short-term COVID-19 reinfection in 543 patients with rheumatic diseases. Psychological health was evaluated using the Functional Assessment of Chronic Illness Therapy Fatigue (FACIT-F) scale, the Patient Health Questionnaire-9 (PHQ-9), the Generalized Anxiety Disorder 7-item (GAD-7) questionnaire, and the Pittsburgh Sleep Quality Index (PSQI) scale. Health status and disease activity were assessed using the EuroQol-5 Dimension-3 Level (EQ-5D-3L) descriptive system and the Visual Analogue Score (VAS) scale. The model performance was assessed by Area Under the Receiver Operating Characteristic Curve (AUC), Area Under the Precision-Recall Curve (AUPRC), and the geometric mean of sensitivity and specificity (G-mean). SHapley Additive exPlanations (SHAP) analysis was used to interpret the contribution of each predictor to the model outcomes.

resultsThe eXtreme Gradient Boosting (XGBoost) model demonstrated superior performance with an AUC of 0.91 (95% CI 0.87-0.95). Significant factors of short-term reinfection included glucocorticoid taper (OR = 2.61, 95% CI 1.38-4.92), conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) taper (OR = 2.97, 95% CI 1.90-4.64), the number of symptoms (OR = 1.24, 95% CI 1.08-1.42), and GAD-7 scores (OR = 1.07, 95% CI 1.02-1.13). FACIT-F scores were associated with a lower likelihood of short-term reinfection (OR = 0.95, 95% CI 0.93-0.96). Besides, we found that the GAD-7 score was one of the most important predictors.

conclusionWe developed explainable machine learning models to predict the risk of short-term COVID-19 reinfection in patients with rheumatic diseases. SHAP analysis highlighted the importance of clinical and psychological factors. Factors included anxiety, fatigue, depression, poor sleep quality, high disease activity during initial infection, and the use of glucocorticoid taper were significant predictors. These findings underscore the need for targeted preventive measures in this patient population.

Indexed as

AlgorithmsCOVID-19ReinfectionRheumatic DiseasesAdultAgedFemaleHumansMachine LearningMaleMiddle AgedRisk FactorsROC CurveSARS-CoV-2Surveys and QuestionnairesCOVID-19Machine learningPsychological factorsRheumatismSHAP analysisShort-term reinfectionXGBoost

Identifiers

PMID39719617
PMCPMC11668030

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.